Epidermal EGFR controls cutaneous host defense and prevents inflammation. - Wikidata - awgldk - TriplyDB

Epidermal EGFR controls cutaneous host defense and prevents inflammation.

Epidermal EGFR controls cutaneous host defense and prevents inflammation.

http://www.wikidata.org/entity/Q47728732

about

Mechanisms underlying skin disorders induced by EGFR inhibitors RNase 7 in Cutaneous Defense Cutaneous adverse reactions specific to epidermal growth factor receptor inhibitors Acneiform Rash Induced by EGFR Inhibitors: Review of the Literature and New Insights Epidermal RAF prevents allergic skin disease Epithelial inflammation resulting from an inherited loss-of-function mutation in EGFR Changes in sebum levels and the development of acneiform rash in patients with non-small cell lung cancer after treatment with EGFR inhibitors Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation.Infection of keratinocytes with Trichophytum rubrum induces epidermal growth factor-dependent RNase 7 and human beta-defensin-3 expression.Dysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic Dermatitis.iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling The Inflammasome and the Epidermal Growth Factor Receptor (EGFR) Are Involved in the Staphylococcus aureus-Mediated Induction of IL-1alpha and IL-1beta in Human Keratinocytes.Nasal vestibulitis due to targeted therapies in cancer patients.Antibiotic prophylaxis for skin toxicity induced by antiepidermal growth factor receptor agents: a systematic review and meta-analysis.Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potency.Multitasking basal cells: combining stem cell and innate immune duties.The EGF receptor ligand amphiregulin controls cell division via FoxM1 Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair.Preclinical studies of a Pro-antibody-drug conjugate designed to selectively target EGFR-overexpressing tumors with improved therapeutic efficacy.Epidermal growth factor receptor inhibitors trigger a type I interferon response in human skin.Immunological visibility: posttranscriptional regulation of human NKG2D ligands by the EGF receptor pathway.Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors.Biology of the eyelash hair follicle: an enigma in plain sight.Efficacy of recombinant bovine epidermal growth factor in the treatment of experimental subclinical Staphylococcus aureus mastitis in a ewe model.Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature.EGFR inhibitor-induced skin reactions: differentiating acneiform rash from superimposed bacterial infections.Cell autonomous or systemic EGFR blockade alters the immune-environment in squamous cell carcinomas.Identifying and Creating the Next Generation of Community-Based Cancer Prevention Studies: Summary of a National Cancer Institute Think Tank.EGFR inhibitors erlotinib and lapatinib ameliorate epidermal blistering in pemphigus vulgaris in a non-linear, V-shaped relationship.ADAM17/EGFR axis promotes transglutaminase-dependent skin barrier formation through phosholipase C γ1 and protein kinase C pathways.Mechanisms of skin aging induced by EGFR inhibitors.Preventing or treating anti-EGFR related skin rash with antibiotics?RNase 7 participates in cutaneous innate control of Corynebacterium amycolatum.Genetic ablation of epidermal EGFR reveals the dynamic origin of adverse effects of anti-EGFR therapy.E-cadherin integrates mechanotransduction and EGFR signaling to control junctional tissue polarization and tight junction positioning.Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.Functional Genomics Approach Identifies Novel Signaling Regulators of TGFα Ectodomain Shedding.Epidermal Growth Factor Receptor Signaling Disruption by Endocrine and Metabolic Disrupting Chemicals.Skinflammation and drug toxicity--a delicate balance.Purpuric Drug Eruptions Caused by Epidermal Growth Factor Receptor Inhibitors for Non-Small Cell Lung Cancer: A Clinicopathologic Study of 32 Cases.

P2860

Q26745689-2C0CDDB6-6ECA-430B-A675-8F170F4FC5DC Q26752767-7D220A23-C08C-444F-B672-6F8B46D37EE3 Q26781472-F88C89CB-B26E-469C-99C3-FFC98D130882 Q28081446-B5C2F002-64DF-4E71-B414-E9EF0C7AC601 Q28829587-105BDA72-2FAC-4335-9C2E-82A5FE0D6C12 Q30415389-D9749848-70F9-42AC-B7CF-1624D7A0C3C9 Q35043780-C2A9A3DB-4F12-4A1B-BAF6-0923DBFD6F4E Q35086445-668806BB-763C-4902-B7F3-07944C7CF3DD Q35152863-6842D1A8-49B5-447F-8238-FF9EFB6CB5EB Q35532126-EF4FCA27-256F-41F3-909D-60E2FB8F7658 Q35616369-F3D95C8E-E5E4-4DF9-BA32-85A170511BE5 Q35903786-C63E1407-594A-46A3-ABB3-B968CAEE27DE Q35954875-B708E83B-1894-4937-90F3-D6BFA9DEC45F Q36026706-70D19D4E-CFF6-47EB-84A8-4340D7A138E9 Q36213066-AF8A4BC8-5D85-4D0E-9E86-F21B71F5F540 Q36519792-D36D1FFD-D006-45AC-918F-5326BDBBA581 Q36678172-A8718BBE-EB81-4AEF-92A6-6497BA7343AC Q36687542-88B45CB6-54BA-4AA2-A986-15835D44C348 Q37138420-3AA87682-AA4B-4B1C-9A17-399184CE7693 Q37565269-250F5A45-EA18-4341-A35B-2A3F8B5F8377 Q37720812-E718FA64-B487-450E-B20A-E0FDD2249F83 Q38207484-90B05BC7-AB43-47D4-8EEF-A06C32C9E7C0 Q38603091-219FA5CB-AE25-495E-B0E8-A0DF5677B178 Q38648935-4F573F99-CD9D-4F9A-B133-B08E42484363 Q38738465-2685FC4E-A4B7-45C7-BC8F-6258392A72D2 Q38818406-FD24F031-12E1-42B5-B3E0-7DC35ED6940B Q38923746-8D843752-F385-41A3-95B3-8F9FDC08808E Q39037941-651ABDBD-1685-41CF-AE35-410D52CD92E6 Q39307190-EE7C7B25-E25F-4AD9-9FAC-88F281477491 Q39683133-084F6721-586D-4300-B6A2-B089F8563032 Q39778129-368D01C1-996A-452F-872B-DA953DB6A16B Q42398733-67ACF4BE-53AD-46CA-963A-D68B985F3B4E Q42636966-397F6972-B236-4130-A942-427F9DD3B050 Q43521257-CDDB1238-B62F-4ECF-A226-F1CC30AAA90A Q44640093-4E2040D5-C442-4AA8-AF01-4F9C6B32C3AD Q47350013-3D537751-37C8-454B-85F1-826A81B0EBB1 Q47582263-822841A5-A7B5-47A6-B927-765998AA3781 Q47656937-F882FE56-FCF3-46F5-B715-7A113DFA6814 Q47728758-34B5ED84-AD80-4BC3-AC4A-A4FFEDE15415 Q47754320-0E92C90B-3973-4EF6-897A-EB7F16B40BC0

P2860

Epidermal EGFR controls cutaneous host defense and prevents inflammation.

http://www.wikidata.org/entity/Q47728732

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Epidermal EGFR controls cutaneous host defense and prevents inflammation.

@en

Epidermal EGFR controls cutaneous host defense and prevents inflammation.

@nl

type

label

Epidermal EGFR controls cutaneous host defense and prevents inflammation.

@en

Epidermal EGFR controls cutaneous host defense and prevents inflammation.

@nl

prefLabel

Epidermal EGFR controls cutaneous host defense and prevents inflammation.

@en

Epidermal EGFR controls cutaneous host defense and prevents inflammation.

@nl

P1433

Q47728732-6CD714C4-AC80-405A-9BBA-8423E1ED4F30

P1476

Q47728732-5A69DAA6-ACE7-411D-ADFC-17BFA7C34B54

P2093

Q47728732-020C7589-82B3-42D2-AB5E-8C455F7743A0

Q47728732-0E85DA4F-D84C-4295-997C-742B05C81E4C

Q47728732-157C7BBF-950C-4897-9C44-C45D212A9C9A

Q47728732-2935CAEC-764C-4EC4-8FE5-BB30C8AF3652

Q47728732-2FC3EF59-5D2B-4A38-B05F-C71AFE5AD864

Q47728732-44935B24-63B4-4C74-9FA7-9DDEAD2386F2

Q47728732-62420E97-107E-4008-A8D2-53B0FE8D7224

Q47728732-8E76CEE0-65BA-4E40-AC25-40E42A686E33

Q47728732-9BEC7763-28CD-40EB-8E3E-58ACC0D89B48

Q47728732-AB73577C-EB18-42F2-85CD-942E3D3CD46E

P2860

Q47728732-0857B43C-09A2-483B-975E-990ECE221A73

Q47728732-08DEBE86-8F53-4BA7-865D-33CCB1A69A36

Q47728732-0935F0ED-8927-4790-B7C4-9031B53A34C8

Q47728732-0F8C9969-D833-4CD2-BB09-D403CE199BBD

Q47728732-10C67648-CD62-490E-BD28-9ADD56FE7E5C

Q47728732-1717B72E-219D-479F-B58B-A6CB2C69EC16

Q47728732-1FD5B8BE-080B-4645-B616-9F67FB3A8BA3

Q47728732-39241821-A1A1-4713-B8E7-F28A8C62F73B

Q47728732-3EAAB0AA-FF99-4A24-9A2C-29BEB5808E36

Q47728732-3FD89B92-C4FC-4EE2-9253-378218994A3E

P304

Q47728732-B55A4E0F-F42E-442E-9D48-2B3C4C37ECC0

P31

Q47728732-A5BC7450-EBBF-41F2-9A65-5386DAE88E65

P356

Q47728732-C278F7D3-4B69-41C7-8FAB-E32B46CD7941

P407

Q47728732-E4CB7195-D531-4C04-9DD1-BA2A1CD0396D

P433

Q47728732-16B264B2-0BAB-4A60-81DC-BB696AD98B5A

P478

Q47728732-DEF19CF9-57C1-4AC1-9B0B-1D653B6C8AFD

P50

Q47728732-3FA1C8F4-49A5-44F9-B592-F07F9B85471C

Q47728732-4605150B-8047-4683-9124-EA7E1D6C5A0F

Q47728732-DBB5ED32-3A85-48C0-9DBC-A5ECE0549728

P577

Q47728732-BFF07156-597F-4564-B90C-2523E22D82B4

P5875

Q47728732-8DD3797E-5B5A-4C55-8AB9-86BF7A611EDF

P698

Q47728732-779E941C-A385-4A9A-8F69-4C37A9912022

P356

SCITRANSLMED.3005886

P1433

Science Translational Medicine

P1476

Epidermal EGFR controls cutaneous host defense and prevents inflammation.

@en

P2093

Andreas Kislat

http://www.w3.org/2001/XMLSchema#string

Andreas Wollenberg

http://www.w3.org/2001/XMLSchema#string

Bernhard Homey

http://www.w3.org/2001/XMLSchema#string

Bettina A Buhren

http://www.w3.org/2001/XMLSchema#string

Edwin Boelke

http://www.w3.org/2001/XMLSchema#string

Holger Schrumpf

http://www.w3.org/2001/XMLSchema#string

Jens M Schröder

http://www.w3.org/2001/XMLSchema#string

Jens W Fischer

http://www.w3.org/2001/XMLSchema#string

Jürgen Harder

http://www.w3.org/2001/XMLSchema#string

Katharina Röck

http://www.w3.org/2001/XMLSchema#string

P2860

RNase 7 contributes to the cutaneous defense against Enterococcus faecium

Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic

Involvement of chemokine receptors in breast cancer metastasis

RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin

Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart

CCL27-CCR10 interactions regulate T cell-mediated skin inflammation

A peptide antibiotic from human skin

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

Ligand-induced, receptor-mediated dimerization and activation of EGF receptor

Signalling pathways of the TNF superfamily: a double-edged sword

P304

199ra111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3005886

http://www.w3.org/2001/XMLSchema#string

P407

P433

199

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Colin R MacKenzie

Beate M. Lichtenberger

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256076432

http://www.w3.org/2001/XMLSchema#string

P698

23966300

http://www.w3.org/2001/XMLSchema#string